These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

675 related items for PubMed ID: 7812601

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Hyperpolarization by GABAB receptor agonists in mid-brain periaqueductal gray neurones in vitro.
    Chieng B, Christie MJ.
    Br J Pharmacol; 1995 Sep; 116(1):1583-8. PubMed ID: 8564222
    [Abstract] [Full Text] [Related]

  • 4. The mu-opioid receptor antagonist D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP) [but not D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 (CTAP)] produces a nonopioid receptor-mediated increase in K+ conductance of rat locus ceruleus neurons.
    Chieng B, Connor M, Christie MJ.
    Mol Pharmacol; 1996 Sep; 50(3):650-5. PubMed ID: 8794906
    [Abstract] [Full Text] [Related]

  • 5. Opioid inhibition of rat periaqueductal grey neurones with identified projections to rostral ventromedial medulla in vitro.
    Osborne PB, Vaughan CW, Wilson HI, Christie MJ.
    J Physiol; 1996 Jan 15; 490 ( Pt 2)(Pt 2):383-9. PubMed ID: 8821137
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cellular actions of opioids on periaqueductal grey neurons from C57B16/J mice and mutant mice lacking MOR-1.
    Vaughan CW, Bagley EE, Drew GM, Schuller A, Pintar JE, Hack SP, Christie MJ.
    Br J Pharmacol; 2003 May 15; 139(2):362-7. PubMed ID: 12770941
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Potentiation of the excitatory action of NMDA in ventrolateral periaqueductal gray by the mu-opioid receptor agonist, DAMGO.
    Kow LM, Commons KG, Ogawa S, Pfaff DW.
    Brain Res; 2002 May 10; 935(1-2):87-102. PubMed ID: 12062477
    [Abstract] [Full Text] [Related]

  • 12. Postsynaptic actions of substance P on rat periaqueductal grey neurons in vitro.
    Drew GM, Mitchell VA, Vaughan CW.
    Neuropharmacology; 2005 Oct 10; 49(5):587-95. PubMed ID: 15921708
    [Abstract] [Full Text] [Related]

  • 13. Presynaptic mu and delta opioid receptor modulation of GABAA IPSCs in the rat globus pallidus in vitro.
    Stanford IM, Cooper AJ.
    J Neurosci; 1999 Jun 15; 19(12):4796-803. PubMed ID: 10366614
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Dissociation of mu and delta opioid receptor-mediated reductions in evoked and spontaneous synaptic inhibition in the rat hippocampus in vitro.
    Lupica CR, Proctor WR, Dunwiddie TV.
    Brain Res; 1992 Oct 16; 593(2):226-38. PubMed ID: 1360320
    [Abstract] [Full Text] [Related]

  • 16. Antagonizing effect of protein kinase C activation on the mu-opioid agonist-induced inhibition of high voltage-activated calcium current in rat periaqueductal gray neuron.
    Cho YW, Han SH, Min BI, Rhee JS, Akaike N.
    Brain Res; 2001 Oct 19; 916(1-2):61-9. PubMed ID: 11597591
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.